Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Short-Term Debt issuancesShort-Term Debt repayments
Ratios

Myriad Genetics (MYGN) Shares Repurchased (2016)

Historic Shares Repurchased for Myriad Genetics (MYGN) over the last 7 years, with Q4 2016 value amounting to $10.3 million.

  • Myriad Genetics' Shares Repurchased fell 5863.45% to $10.3 million in Q4 2016 from the same period last year, while for Mar 2019 it was $10.3 million, marking a year-over-year change of. This contributed to the annual value of $50.0 million for FY2019, which is N/A changed from last year.
  • Myriad Genetics' Shares Repurchased amounted to $10.3 million in Q4 2016, which was down 5863.45% from $21.3 million recorded in Q3 2016.
  • In the past 5 years, Myriad Genetics' Shares Repurchased registered a high of $102.3 million during Q3 2013, and its lowest value of $10.3 million during Q4 2016.
  • Its 5-year average for Shares Repurchased is $45.6 million, with a median of $44.9 million in 2013.
  • In the last 5 years, Myriad Genetics' Shares Repurchased crashed by 8636.9% in 2012 and then skyrocketed by 27336.11% in 2013.
  • Myriad Genetics' Shares Repurchased (Quarter) stood at $33.7 million in 2012, then soared by 130.99% to $77.8 million in 2013, then decreased by 25.07% to $58.3 million in 2014, then tumbled by 57.29% to $24.9 million in 2015, then plummeted by 58.63% to $10.3 million in 2016.
  • Its Shares Repurchased stands at $10.3 million for Q4 2016, versus $21.3 million for Q3 2016 and $54.7 million for Q2 2016.